The angiogenic effects of vascular endothelial growth factor are mediated predominantly by the FLK-1/KDR receptor. An understanding of the transcriptional control mechanisms underlying flk-1/KDR expression should provide insight into the molecular basis of angiogenesis. In this study, we show that transforming growth factor- 1 (TGF- 1 ) down-regulates expression of the endogenous flk-1/KDR gene in endothelial cells. In transient transfection assays, this effect was mapped to a palindromic GATA site in the 5-untranslated region. In electrophoretic mobility shift assays, the palindromic GATA site was shown to bind to two molecules of GATA protein. Moreover, DNA-GATA interactions were inhibited by TGF- 1 . Finally, in cotransfection assays, transactivation of the flk-1/KDR promoter by GATA-1 or GATA-2 was attenuated in TGF- 1 -treated cells. Taken together, these results suggest that the TGF--1-mediated inhibition of the flk-1/KDR gene is mediated by a 5-untranslated region palindromic GATA site.
Vascular endothelial growth factor (VEGF)1 is an important regulator of new blood vessel formation in both health and disease states. The effects of VEGF are mediated by two high affinity transmembrane receptors, FLK-1/KDR and FLT-1 (1). Of these two receptors, FLK-1/KDR appears to play a more prominent role in VEGF-mediated signaling. FLK-1/KDR is a membrane-bound receptor of the tyrosine kinase family that is expressed exclusively in endothelial cells. The FLK-1/KDR receptor is expressed early in the mouse embryo, where it is believed to play an important role in endothelial cell differentiation and vasculogenesis (2). In the adult, FLK-1/KDR expression is down-regulated (3). However, the gene may be reactivated and/or up-regulated in tumor vascular beds or in the setting of cardiac angiogenesis (4) and proliferative retinopathies (5, 6). In addition, FLK-1/KDR may serve an important role in wound healing and bone remodeling (7).An understanding of the mechanisms that underlie the transcriptional regulation of the flk-1/KDR gene might provide important information about the molecular basis of endothelial cell differentiation and angiogenesis. The human and mouse flk-1/KDR promoters have been sequenced and characterized (8 -12). Under in vitro conditions, the 5Ј-flanking region and first exon have been shown to contain information for endothelial cell-specific expression, whereas in transgenic mouse assays, intronic enhancer sequences play a critical role in mediating expression within the vasculature (13).Although the above studies provide insight into the mechanisms of endothelial cell-specific gene regulation, they do not address the question of how the flk-1/KDR promoter is temporally controlled by positive and negative regulators of angiogenesis. Transforming growth factor- 1 (TGF- 1 ) has a biphasic effect on basic fibroblast growth factor-and VEGF-induced angiogenesis in vitro (14). At low concentrations TGF- 1 enhances endothelial cell response, whereas at high concentrations, TGF- 1 inhibits the effects ...